KEITH PRIDDLE: Open Payments
NPI 1235676099 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,491 in 88 payments from 27 companies in 2025. Trend: 2023 $1,518 · 2024 $1,721 · 2025 $1,491
Food & beverage: $1,491
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 13 | $188 |
| AstraZeneca Pharmaceuticals LP | 5 | $176 |
| ABBVIE INC. | 13 | $174 |
| Novo Nordisk Inc | 12 | $150 |
| Lilly USA, LLC | 10 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $83 |
| PFIZER INC. | 4 | $71 |
| Axsome Therapeutics, Inc. | 2 | $57 |
| Antares Pharma, Inc. | 3 | $46 |
| GlaxoSmithKline, LLC. | 3 | $45 |
Products named: Korlym, FARXIGA, Kerendia, JARDIANCE, Ozempic, UBRELVY, KISUNLA, Auvelity.
Industry payments across IN — which companies pay providers there.
